Prime Minister Kyriakos Mitsotakis is set to have meetings with 20 managing directors and five presidents of associations from the largest multinational biopharmaceutical groups in Athens this week. The top executives of the global pharmaceutical industry are in Greece for their biannual meeting, known as the Biopharmaceutical CEOs Roundtable (BCR). The event is organized by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), which represents over 90 pharmaceutical companies and associations worldwide.
The CEOs will discuss Greece’s potential to expand research and development efforts, increase clinical studies, and leverage artificial intelligence for drug and vaccine discovery. Greece’s access to digitized medical data has the potential to contribute significantly to the development of new medicines. The roundtable serves as a global policy forum where industry leaders tackle health policies impacting biomedical innovation.
Key participants at the meeting include Albert Bourla of Pfizer, Hubertus von Baumbach of Boehringer-Ingelheim, Christopher Boerner of BMS, Elcin Barker Ergun of Menarini, Robert Davis of MSD, and Joaquin Duato of Johnson & Johnson. The gathering aims to promote collaboration and knowledge sharing among industry experts to advance healthcare solutions globally.
The event highlights the importance of international cooperation in driving innovation and addressing health challenges on a global scale. Greece’s role in fostering research and development efforts, clinical studies, and leveraging new technologies underscores the country’s commitment to advancing healthcare solutions. As the industry continues to evolve, collaborations like the BCR provide a platform for industry leaders to exchange ideas and explore opportunities for future growth and innovation.
